Page 1

Quarterly Statement for Q3 2021 June 1 to August 31 , 2021 Gerresheimer on growth course Strong revenue growth : 9.8 % organic increase in core business revenue - Strategic realignment to become an innovative solution provider for biotech , pharma and beauty shows effect Adjusted EBITDA margin in core business at 20.9 % organically - Adjusted earnings per share see organic increase of 5.2 % - Guidance confirmed for the financial year 2021 Contents 2 Key figures for the Gerresheimer Group 3 Revenue , adjusted EBITDA , and financial position gerresheimer 5 Forecast for 2021 6 Financial Information 11 Additional Information